Education
About Us
Working with TipRanks
Follow Us
Zoetis (ZTS)
NYSE:ZTS
Earnings Data
Report Date
Oct 30, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
1.64Last Year’s EPS
1.58Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance with significant organic revenue growth across various segments, particularly in the International domain and key franchises like Simparica and Dermatology. However, challenges such as Librela's adoption issues and tariff impacts are notable concerns. Despite these lowlights, the company's raised guidance and robust growth metrics across diverse portfolios contribute to a positive outlook.Company Guidance
Strong Organic Revenue Growth
Zoetis delivered 8% organic operational revenue growth and 10% adjusted net income growth on an organic operational basis for Q2 2025, showcasing strength in innovation and operational efficiency.
International Segment Growth
The International segment experienced a 9% increase in organic operational revenue, driven by regional market expansion and sustained demand.
Simparica Franchise Performance
The Simparica franchise grew 17% operationally, with Simparica Trio delivering 20% operational revenue growth, maintaining its leadership in the parasiticide market.
Key Dermatology Franchise Success
Key Dermatology franchise grew 11% operationally, driven by strong international performance and high compliance, with Apoquel Chew and Cytopoint contributing to the growth.
Livestock Segment Momentum
Livestock delivered 6% organic operational growth with double-digit gains internationally, aided by strong demand in swine, fish, and poultry portfolios.
Raised Full-Year Guidance
Zoetis raised its full-year guidance for organic operational revenue growth to 6.5% to 8% and organic operational growth in adjusted net income to 5.5% to 7.5%.
ZTS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ZTS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2025 | $151.81 | $146.12 | -3.75% |
May 06, 2025 | $157.53 | $149.37 | -5.18% |
Feb 13, 2025 | $172.72 | $163.83 | -5.15% |
Nov 04, 2024 | $180.19 | $173.48 | -3.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Zoetis (ZTS) report earnings?
Zoetis (ZTS) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).
What is Zoetis (ZTS) earnings time?
Zoetis (ZTS) earnings time is at Oct 30, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZTS EPS forecast?
ZTS EPS forecast for the fiscal quarter 2025 (Q3) is 1.64.
